United States – October 27, 2026 -- Solid Biosciences has expanded its INSPIRE DUCHENNE gene therapy trial to 43 participants and now accepts children aged 4 to under 12, up from the previous range of 4 to under 8.

Three participants dosed with no serious adverse events

INSPIRE DUCHENNE is a first-in-human, multicenter, Phase 1/2 open-label study. It tests the safety, tolerability and efficacy of a single intravenous infusion of SGT-003, a next-generation AAV gene therapy candidate, in ambulant boys with Duchenne.

Little Rock – September 12, 2026 -- The American Association of Kidney Patients (AAKP) will host its 51st annual National Patient Meeting September 10-13, 2026, in Little Rock, Arkansas, with free admission and meals for kidney patients, family members, care partners, and living organ donors. Pre-registration is encouraged online or by calling (800) 749-2257.

Little Rock – September 04, 2026 -- Kidney patients, family caregivers, and living organ donors can attend a four-day national meeting on kidney disease treatment and transplants at no cost starting September 10.

The American Association of Kidney Patients (AAKP) is hosting its 51st annual National Patient Meeting from September 10-13 in Little Rock, Arkansas. Admission and meals are free, with pre-registration available online or by calling (800) 749-2257.